ANTIPLATELET THERAPY
Clinical trials for ANTIPLATELET THERAPY explained in plain language.
Never miss a new study
Get alerted when new ANTIPLATELET THERAPY trials appear
Sign up with your email to follow new studies for ANTIPLATELET THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less be more? shorter blood thinner course after stent may cut bleeding in seniors
Disease control Not yet recruitingThis study looks at whether older adults (65+) who get a heart stent can safely stop one of their two blood thinners (aspirin) after just 7 days instead of taking it for months. The goal is to lower the chance of serious bleeding without increasing the risk of heart attack, strok…
Matched conditions: ANTIPLATELET THERAPY
Phase: PHASE3 • Sponsor: Vincent ROULE • Aim: Disease control
Last updated May 25, 2026 21:48 UTC
-
Heart patients may ditch blood thinners after one year, new study hopes to prove
Knowledge-focused Not yet recruitingThis study looks at whether people who had a heart procedure with a drug-coated balloon can safely stop taking antiplatelet medication (blood thinners) after 12 months. Researchers will compare those who stop versus those who continue, tracking heart events and bleeding risks. Ab…
Matched conditions: ANTIPLATELET THERAPY
Phase: NA • Sponsor: Ulsan University Hospital • Aim: Knowledge-focused
Last updated May 25, 2026 21:49 UTC